<DOC>
	<DOCNO>NCT01434485</DOCNO>
	<brief_summary>The purpose study confirm safety profile / factor impact safety efficacy Nexium capsule daily clinical usage patient prescribe Nexium `` gastric ulcer '' , `` duodenal ulcer '' , `` anastomotic ulcer '' , `` reflux oesophagitis '' , `` non-erosive reflux disease '' , `` Zollinger-Ellison syndrome ''</brief_summary>
	<brief_title>Nexium Capsules Clinical Experience Investigation</brief_title>
	<detailed_description>Nexium capsule Clinical Experience Investigation</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Zollinger-Ellison Syndrome</mesh_term>
	<mesh_term>Gastrinoma</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Patients treat Nexium first time due gastric ulcer , duodenal ulcer , anastomotic ulcer , reflux oesophagitis , nonerosive reflux disease , ZollingerEllison syndrome . None</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>gastric ulcer , duodenal ulcer , anastomotic ulcer , reflux oesophagitis , non-erosive reflux disease , Zollinger-Ellison syndrome , Nexium</keyword>
</DOC>